LeoPARDS - An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-005159-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The main objectives of this trial are: 1. To ascertain if levosimendan reduces the incidence and severity of organ failure as compared to placebo in adult patients who have septic shock. 2. To identify the effect of levosimendan on the function of individual organs function in septic shock. 3. To establish the safety profile and the metabolism of levosimendan by the body in this group of patients.


Critère d'inclusion

  • Septic shock

Liens